
Prader-Willi syndrome (PWS) is a rare genetic disorder characterized by intellectual disabilities, physical abnormalities, obesity, and behavioral issues. Common symptoms include poor muscle tone, difficulty feeding, short stature, incomplete sexual development, chronic feeling of hunger, and temper tantrums. The disorder arises due to loss of function of Paternally Expressed Genes on chromosome 15. Treatment options aim to manage symptoms and improve the quality of life of the patients. Pharmaceutical companies are developing drugs targeting the genetic causes and symptoms of PWS.
The Prader-Willi Syndrome (PWS) market is estimated to be valued at USD 0.916 Bn in 2024 and is expected to reach USD 1.47 Bn by 2031, growing at a compound annual growth rate (CAGR) of 7% from 2024 to 2031.
Key players operating in the Prader-Willi syndrome (PWS) treatment market are Chiasma, Millendo Therapeutics, Roche, Novartis and Pfizer.Increasing awareness initiatives by patient advocacy groups and research funding from government and private organizations are expected to generate opportunities in the market. Development of therapies targeting the genetic defects and growth hormone dysfunction could provide momentum.North America dominates the global Prader-Willi Syndrome (PWS) Treatment Market gowing to the high diagnosis rates and availability of advanced therapies. However, the Asia Pacific region is anticipated to emerge as a lucrative market attributed to improving healthcare infrastructure and rising disposable income.
Market Drivers
The increasing research efforts towards developing novel therapeutics targeting different aspects of PWS pathology are expected to drive the market during the forecast period. For instance, Chiasma’s oral octreotide candidate could see approval by 2024 to treat hyperphagia and related behaviors in PWS patients. Furthermore, gene therapies showing potential in animal models are expected to enter clinical trials boosting the market.
PEST Analysis
Political: The policies and regulations set by government authorities have an impact on the growth of the Prader-Willi Syndrome market. The funding for research activities related to rare diseases affects drug development.
Economic: The rising healthcare expenditure, increasing disposable incomes, and growing awareness about available treatment options has been fueling the growth of the Prader-Willi Syndrome market.
Social: The social acceptance and support received from communities can influence people suffering from Prader-Willi Syndrome to seek proper treatment. Non-profit organizations spreading awareness also impact the market.
Technological: Advancements in genetic analysis techniques, diagnostic methods, and drug discovery approaches are enhancing the treatment landscape. Connected drug delivery devices and therapeutics are boosting market expansion.The geographical region where the Prader-Willi Syndrome market in terms of value is concentrated currently is North America. This is primarily due to the strong presence of major industry players, rising healthcare expenditure, and growing patient awareness levels in the US and Canada. Europe is also among the prominent revenue generating regions attributable to increasing government support for rare disease research.The Asia Pacific region is anticipated to witness the fastest growth in the Prader-Willi Syndrome market over the forecast period. This is attributed to factors such as rising healthcare spending, growing economy, expansion of private healthcare insurance, increasing population, and increasing investments by key market players exploring business opportunities. Emerging nations like India, China, and South Korea are expected to fuel the marketgrowth in the coming years. Improving healthcare infrastructure and facilities in the rural areas also contribute positively to market development in Asia Pacific.
Get this Report in Japanese Language: プラダーウィリ症候群(PWS)治療市場
Get this Report in Korean Language: 프라더윌리증후군(PWS) 치료 시장
Author Bio:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163